You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 149 No. 12, December 1989 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (85)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Screening for the Multiple Endocrine Neoplasia Syndrome Type I

A Study of 11 Kindreds in the Netherlands

Hans F. A. Vasen, MD; Cornelis B. H. W. Lamers, MD; Cees J. M. Lips, MD

Arch Intern Med. 1989;149(12):2717-2722.


Abstract



• Since 1974, a total of 11 families with the multiple endocrine neoplasia syndrome type I (MEN-I), including 52 patients, were identified. Fifteen of these 52 patients died of MEN-I—related complications (mean age, 44 years), most of them in the period before screening was started. In 11 of the 15 patients, death was caused by complicated peptic ulcer disease, in 2 by metastasis of an endocrine pancreatic tumor, and in 2 by renal failure due to hyperparathyroidism. Family screening led to the diagnosis of 43 new endocrine lesions: 21 cases of hyperparathyroidism, 16 endocrine pancreatic tumors, and 6 pituitary tumors. Hyperparathyroidism either was the first manifestation of MEN-I or was diagnosed simultaneously with the other components of the syndrome in 44 (94%) of the 47 patients who underwent full evaluation.

(Arch Intern Med. 1989;149:2717-2722)



Author Affiliations



From the Foundation for the Detection of Hereditary Tumors, Utrecht, the Netherlands (Dr Vasen); Department of Gastroenterology, University Hospital, Leiden, the Netherlands (Dr Lamers); and Department of Internal Medicine, University Hospital, Utrecht (Dr Lips).


Footnotes



Accepted for publication July 17, 1989.

Reprint requests to Foundation for the Detection of Hereditary Tumors, PO Box 12.009, 3501 AA Utrecht, the Netherlands (Dr Vasen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile
Lourenco et al.
Eur J Endocrinol 2008;159:259-274.
ABSTRACT | FULL TEXT  

Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
Halfdanarson et al.
Endocr Relat Cancer 2008;15:409-427.
ABSTRACT | FULL TEXT  

Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype-phenotype correlation
Vierimaa et al.
Eur J Endocrinol 2007;157:285-294.
ABSTRACT | FULL TEXT  

Hereditary Cancer Predisposition Syndromes
Garber and Offit
JCO 2005;23:276-292.
ABSTRACT | FULL TEXT  

Multiple Endocrine Neoplasia Type 1 Variant with Frequent Prolactinoma and Rare Gastrinoma
Hao et al.
J. Clin. Endocrinol. Metab. 2004;89:3776-3784.
ABSTRACT | FULL TEXT  

Familial Isolated Hyperparathyroidism Is Rarely Caused by Germline Mutation in HRPT2, the Gene for the Hyperparathyroidism-Jaw Tumor Syndrome
Simonds et al.
J. Clin. Endocrinol. Metab. 2004;89:96-102.
ABSTRACT | FULL TEXT  

Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients
Cebrian et al.
J. Med. Genet. 2003;40:e72-72.
FULL TEXT  

Prospective Study of the Natural History of Gastrinoma in Patients with MEN1: Definition of an Aggressive and a Nonaggressive Form
Gibril et al.
J. Clin. Endocrinol. Metab. 2001;86:5282-5293.
ABSTRACT | FULL TEXT  

Pituitary Macroadenoma in a 5-Year-Old: An Early Expression of Multiple Endocrine Neoplasia Type 1
Stratakis et al.
J. Clin. Endocrinol. Metab. 2000;85:4776-4780.
ABSTRACT | FULL TEXT  

Four Cases of Mucosal Neuroma Syndrome: Multiple Endocrine Neoplasm 2B or Not 2B?
Gordon et al.
J. Clin. Endocrinol. Metab. 1998;83:17-20.
FULL TEXT  

Multiple Endocrine Neoplasm, Type 1: Gastrinomas, Pancreatic Neoplasms, Microcarcinoids, the Zollinger-Ellison Syndrome, Lymph Nodes, and Hepatic Metastases
Shepherd et al.
Arch Surg 1993;128:1133-1142.
ABSTRACT  

Cause of Death in Multiple Endocrine Neoplasia Type 1
Wilkinson et al.
Arch Surg 1993;128:683-690.
ABSTRACT  

The Natural History of Multiple Endocrine Neoplasia Type 1: Highly Uncommon or Highly Unrecognized?
Shepherd
Arch Surg 1991;126:935-952.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.